New search Hide text from Guidelines
M MUSCULO-SKELETAL SYSTEMM09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
This group comprises preparations used in disorders of the musculo-skeletal system, which cannot be classified in the preceding groups.
M09AX Other drugs for disorders of the musculo-skeletal system
Hyaluronic acid injection for intraarticular administration (e.g. 2.5 mg/ampoule) used in the treatment of arthritis is classified in this group. Hyaluronic acid injection used during surgical procedures on the eye (e.g. 4-20 mg/ampoule) is classified in S01K.
Mexiletine indicated for myotonic disorders is classified in C01BB.
| The DDD for hyaluronic acid is based on intraarticular treatment of arthritis. The DDD is assigned according to daily dose even if the product is given as weekly injections. |
| ATC code | Name | DDD | U | Adm.R | Note |
| M09AX01 | hyaluronic acid | 3.6 | mg | P | intraarticular |
| M09AX02 | chondrocytes, autologous | ||||
| M09AX03 | ataluren | 2.8 | g | O | |
| M09AX04 | drisapersen | ||||
| M09AX05 | aceneuramic acid | ||||
| M09AX06 | eteplirsen | ||||
| M09AX07 | nusinersen | 0.1 | mg | P | |
| M09AX08 | golodirsen | ||||
| M09AX09 | onasemnogene abeparvovec | ||||
| M09AX10 | risdiplam | 5 | mg | O | |
| M09AX11 | palovarotene | ||||
| M09AX12 | viltolarsen | ||||
| M09AX13 | casimersen | ||||
| M09AX14 | givinostat | ||||
| M09AX15 | delandistrogene moxeparvovec |
Last updated: 2024-12-27